Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 9/4/2024China Issues New Guidelines to Improve Rural Public Health
  • 9/4/2024Innovent Granted U.S. Fast Track Designation for Advanced Melanoma Mo...
  • 9/4/2024EpimAb and Vignette Enter Strategic Deal to Develop BCMA×CD3 bsAb
  • 9/3/2024CDE Solicits Comments on Draft of the Technical Guidelines for Vaccine...
  • 9/3/2024Hygieia Pharma Secures Series A2 Financing, Raising Tens of CNY Millio...
  • 9/3/2024CGeneTech Completes Series C Financing, Secures Over CNY 100M
  • 9/3/2024Simcere Zaiming Collaborates with TargetRx to introduce A Third-genera...
  • 9/2/2024Navigator Medicines Announces $100M Series A Financing and In-Licensin...
  • 9/2/2024YolTech Enters Licensing Deal with Salubris for Development and Commer...
  • 8/30/2024Recent Executive Moves
  • 8/30/2024CDE Issues the List of Reference Formulations for GQCE Studies (82nd B...
  • 8/30/2024NMPA Suspends Import, Sales and Use of Dr. Reddy's Atomoxetine Hcl Cap...
  • 8/30/2024Virogin Biotech Won Chinese Breakthru Therapy Deisgnation for HCC Drug...
  • 8/30/2024HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...
  • 8/30/2024Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor...
  • 8/29/2024U.S. Government Funding Yields Over 1,000 Patents for China-Based Rese...
  • 8/29/2024CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
  • 8/28/2024Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Develop...
  • 8/27/2024Duality Biothera Seeks Hong Kong IPO to Advance BioNTech-Collaborated ...
  • 8/27/2024Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab
  • 8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
  • 8/27/2024Sanofi Suspends Supply and Sale of Flu Vaccine in China
  • 8/27/2024Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
  • 8/27/2024NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 8/26/2024Over 70% of Village Clinics Now Covered by the BMI System
  • 8/26/2024China Escalates Crackdown on Medical Insurance Frauds
  • Page:51/55 Total number of articles:1623: [First][<<] [49] [50] [51] [52] [53] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group